Health
301 articles · breaking coverage & in-depth analysis
How the Brain’s Own Immune Cells Fuel Aggressive Childhood Tumors
A new study reveals that the brain's immune cells are being hijacked to fuel aggressive childhood tumors. This discovery identifies a potential new target for treatment.
The $1.6 Million Question: Why Gene Therapy for Sickle Cell Isn't Winning
A new study reveals that stem cell transplants are more cost-effective than gene therapy for sickle cell disease. Here is what this means for patients and health systems.
Insulin Resistance and PCOS: The Metabolic Link Doctors Are Finally Mapping
Insulin resistance is the engine driving most PCOS symptoms. New research suggests that shifting focus to metabolic health is the key to effective treatment.
Alcohol’s Hidden Chain Reaction: How It Damages More Than Just the Liver
New research shows that chronic alcohol use triggers a systemic chain reaction, damaging the gut, liver, and metabolism simultaneously. Scientists are now looking at the gut microbiome as a potential target for new treatments.
A New Cancer Injection Is Clearing Tumors When Everything Else Fails
A new cancer injection, amivantamab, has shown the ability to clear tumors in patients who had previously failed all standard treatments. The drug's unique dual-action mechanism could redefine care for advanced head and neck cancer.
Why Standard Gynecomastia Surgery Often Fails Asian Patients
New research suggests that standard gynecomastia surgery often misses the mark for Asian men. A study of 550 cases highlights why specialized techniques are essential for better results.
ViiV Healthcare’s New PrEP Campaign Targets the 'Choice Gap' in HIV Prevention
ViiV Healthcare is launching a new campaign to address the 'choice gap' in HIV prevention. The effort focuses on shifting the conversation toward long-acting injectable options.
The Global Mental Health Surge: Why the Crisis Is Shifting Younger
A global study reveals that mental health disorders have nearly doubled since 1990. The most concerning trend is the shift in peak burden to the 15-to-19 age group.
Waters’ New Mass Spectrometer Just Cracked the Code on Protein Misfolding
Waters Corporation has unveiled the Cyclic IMS P20, a new mass spectrometer platform designed to detect disease signals with 10x greater sensitivity. The system aims to accelerate drug discovery by mapping molecular structures in unprecedented detail.
A Personalized mRNA Vaccine Has Cut Melanoma Recurrence by Half
A new personalized mRNA vaccine has cut the risk of melanoma returning by nearly 50 percent over five years. The findings offer a potential breakthrough in preventing cancer recurrence for high-risk patients.
A Rare Cancer, A £120,000 Bill, and One Woman’s Race Against Time
After exhausting clinical trials, Amanda Clark is turning to the public to fund a £120,000 liver treatment. She is racing to secure the care before her cancer progresses.
Migraine With Aura Linked to Higher Stroke Risk in Older Men
A new study reveals that men under 72 with migraine with aura face a significantly higher risk of ischemic stroke. The findings suggest a need for targeted stroke prevention counseling.